Optinose price target adjusted for stock split at Lake Street
Lake Street analyst Thomas Flaten lowered the firm’s
price target
on Optinose (
OPTN
) to $17 from $45 and keeps a Buy rating on the shares, saying that “in part accounting for the recent 1-for-15 reverse stock split, we revised our $3
price target
to $17″ after OptiNose delivered preliminary XHANCE revenue for Q4 of $22.4M, which was above the firm’s and consensus estimates.
Stay Ahead of the Market:
Published first on
TheFly
– the ultimate source for real-time, market-moving breaking financial news.
Try Now>>